A study compared 3 months versus 6 months of adjuvant chemotherapy for stage III colon cancer. The study did not show non-inferiority for 3 months of treatment overall, but subgroup analysis suggested that 3 months of CAPOX chemotherapy may be sufficient for low-risk colon cancer patients.